Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. NUVISAN, a formerly independent, family-owned contract research organization (CRO), has grown significantly over the years and has expanded its services and capabilities to meet the changing needs of its clients. Operating under the name NUVISAN since 2010, ALS Limited, the global leader in testing, acquired NUVISAN on April 1, 2024, forming the most advanced drug discovery and development organization and providing solutions across continents. We are pleased to offer the following portfolio of services: • Target Identification and Validation • Target-to-Lead • Lead-to-Candidate • Preclinical • Clinical Our services can be provided as stand-alone or integrated solutions and can be customized to your project. To find out more, visit us: www.nuvisan.com or send an email: hello@nuvisan.com.